Pharmaceutical News and Articles

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals, Inc. (Nasdaq AMLX) ( Amylyx or the Company ) today announced the design of its pivotal Phase 3 LUCIDITY clinical trial for avexitide, an

FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer

Even Minutes-Long Exercise 'Bursts' Can Help Women's Hearts

Take the stairs. Tote heavy shopping bags. Walk up that hill. Play tag with a kid or a pet. Weaving these tiny bursts of vigorous physical activity into everyda

As 'Teletherapy' Takes Hold, Nearly 12% of Young Adults Now Undergo Psychotherapy

Access to psychotherapy has increased substantially among Americans, particularly young adults, a new study has found. About 12 of young adults received psychot

Small Amounts of Vigorous Activity Beneficial for Nonexercising Women

Small amounts of vigorous intermittent lifestyle physical activity (VILPA) are associated with significant reductions in the risk for major adverse cardiovascul

Many PCPs Prescribe Antibiotics for Pneumonia Even With Negative Chest X-Ray

Many general practitioners prescribe antibiotics for suspected community-acquired pneumonia (CAP) even when chest radiograph (CR) results are negative, accordin

Could High-Fructose Corn Syrup in Foods Help Speed Cancer?

The sugar known as fructose could be a kind of rocket fuel for cancer cells, and lowering fructose intake could be one way to fight the disease, new research su

Inflammatory Bowel Disease on the Rise Globally in the Elderly

Inflammatory bowel disease (IBD) in older adults has become a global public health burden, according to a study published in the Jan. 31, 2025, issue of Autoimm

Study Looks at Impact of Children's Exposure to Lead in the United States

Children s exposure to lead in the United States has had a significant impact on mental illness symptomatology and disadvantageous personality differences, acco

Cardiovascular Risk and Obesity Affect Brain Volume in Middle Age

The strongest influence of cardiovascular risk and obesity on reduced brain volume is seen between 55 and 64 years of age in men and between 65 and 74 years in